ADCES21 was held virtually August 12-15th. Medtronic Diabetes was a sponsor/exhibitor at the Gold Level. Register to view the recorded sessions until November 8th, 2021.
Throughout the conference, attendees visited the Medtronic Diabetes virtual booth to learn about “The Right Solution at the Right Time.” You too can visit the virtual booth today by clicking here; no registration is required! Once inside, you’ll be able to learn more about what Medtronic Diabetes has to offer.
Consistent themes were also observed throughout the conference. They included diabetes care during a pandemic, the use of telehealth and the benefits of the use of diabetes data and connected devices. Below is a brief overview of some of the presentations.
Janice MacLeod, MA, RD, CDCES, FA, DCES & Jennifer Okemah, MS, RDN, CSSD, BC-ADM, CDCES presented Informed Insulin Delivery Decision-Making with Smart Diabetes Technology. Janice MacLeod pointed out the disparities between races in the use of diabetes technology among people living with diabetes. Most notably, seventy-two percent of white youth vs only 18% of black youth living with T1DM use insulin pumps (1). The call to action is that all patients should play an active role in making their own decisions related to technology use; a process or framework better known as shared-decision making. ADCES has recently adopted the “Identify, Configure, Collaborate (ICC)” Model and has been explained in the context of patient-centered data drive care (2). The use of this model can help address disparities and overcome therapeutic inertia. Jennifer Okemah reported results of a 2020 ADCES survey of > 700 people taking insulin which found 62% reported not logging insulin dose details for reasons of being too busy or forgetting. Eighty percent of these same people surveyed believe having a device that automatically logs insulin dose data would be helpful (3).
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP presented Building A Data-Driven Smart Insulin Delivery Practice during which she also encouraged use of the ICC model to help improve diabetes patient outcomes. Some practical ways educators can help patients succeed include recognizing that patient choices will change over time, setting clear expectations for patients’ use of technology and helping to address barriers. A very helpful resource guide for smart pen technology was published last year (4).
Hope Warshaw, MMSc, RD, CDE, BC-ADM, FADCES presented Connected Insulin Pens & CGM Improve Insulin Injection Outcomes. This hands-on learning session started out with showing real-world data of InPen™ users achieving a statistically significant reduction in Time-Below-Range (5). Case-studies were shared to show how the data from the InPenTM is utilized.
If you’re interested in learning more about these or any other Medtronic Diabetes product, contact your local representative. You can also find more information on our Healthcare Professional website.
Willi SM, Miller KM, DiMeglio LA, et al. Racial-ethnic disparities in management and outcomes among children with type 1 diabetes. Pediatrics. 2015 Mar;135(3):424-34.
Greenwood, D. A., Howell, F., Scher, L., et al. A Framework for Optimizing Technology-Enabled Diabetes and Cardiometabolic Care and Education: The Role of the Diabetes Care and Education Specialist. The Diabetes Educator. 2020 Aug; 46(4), 315–322.
National survey reveals people living with diabetes feel they are doing everything they can to manage their condition yet believe more can be done. Press Release: ADCES website. October 19, 2020. Accessed August 18, 2021.
Warshaw H, Isaacs D, MacLeod J. The Reference Guide to Integrate Smart Insulin Pens Into Data-Driven Diabetes Care and Education Services. Diabetes Educ. 2020 ug;46(4_suppl):3S-20S.
Medtronic Diabetes data; not published.